Login to Your Account

ARYx Raises $25M To Develop Drugs Using Retrometabolics

By Brady Huggett

Wednesday, July 3, 2002
ARYx Therapeutics Inc. raised $25 million in a Series C round of financing - it's largest to date - and will use the funds to continue its progress as the Volvo of the drug industry. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription